|
|
|
| home > white papers > Crunch Time: The Impact of Serialisation Requirements on Packaging Operations - PCI Pharma Services |
|
|
 WHITE PAPERS |
|
PCI Pharma Services
|
|
Crunch Time: The Impact of Serialisation Requirements on Packaging Operations
|
|
The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce
First-of-its-kind technology from
Cellesce creates consistent patient-derived organoids for large scale
drug screening. Acquisition strengthens Molecular Devices’ position as a
3D biology solutions innovator. Combined expertise will accelerate
industry adoption of physiologically-relevant cell models for drug
discovery.
More info >> |
|
 |
White Papers |
 |
|
Key to Outsourcing Method Development and Validation A Pragmatic Approach
RSSL
In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
More info >> |
|
|
|
